obesity

News

UK spurs prescribing of obesity jab Mounjaro with GP bonus

Doctors in the UK will be given thousands of pounds in bonus payments from April for prescribing Eli Lilly's weight-loss drug Mounjaro.

News

Cartoon graphic of a woman with glasses holding thought bubbles in the palm of either hand, one with a check and one with a cross

Head-to-head trial dents Novo Nordisk's obesity hopes

Novo Nordisk slumps as its two-drug combination for weight loss, CagriSema, performs less well than Eli Lilly's rival Zepbound in a comparative trial.

News

Kailera, Hengrui stake claim to oral weight loss category

Chasing Novo Nordisk and Eli Lilly, Kailera and Hengrui have reported 12.1% weight loss in phase 2 with their oral GIP/GLP-1 agonist ribupatide.

News

AstraZeneca raises guidance on stellar cancer drugs growth

AZ reports strong financial results for 2025, and provides a first peek at the data for its oral GLP-1 contender elecoglipron.

News

Hims & Hers copies Novo Nordisk's new Wegovy pill

Competition has already arrived for Novo Nordisk's Wegovy pill, as telehealth company Hims & Hers launches a compounded version.

News

Lilly says 2026 looks good, as sales rocket in Q4

Eli Lilly is predicting strong sales and profit growth in 2026, seemingly shrugging off the pricing pressure that weighed heavily on Novo Nordisk.

UK spurs prescribing of obesity jab Mounjaro with GP bonus

Head-to-head trial dents Novo Nordisk's obesity hopes

Kailera, Hengrui stake claim to oral weight loss category

AstraZeneca raises guidance on stellar cancer drugs growth

Hims & Hers copies Novo Nordisk's new Wegovy pill

Lilly says 2026 looks good, as sales rocket in Q4

Adecto, Aviceda wind down, as Caribou seeks options

Discover a new era of healthcare panel engagement: Grounded ...

obesity

Editor's Picks